Description
Capmatinib
Each film -coated Lucicapma tablet contains: Capmatinib HCL (anhydrous) 235.40 mg equivalent to Capmatinib … 200mg.
INDICATION
LuciCapma is for the treatment of adult patients with metastatic non -small cell lung cancer (NSCLC).
DOSAGE AND USE
Recommended dosage: 400 mg orally twice daily with or without food. Tablets should be swallowed whole & not chewed or crushed.
STORAGE
In a dry place and store at 20°C to 25°C
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of the reach of Children. Do not administer LuciCapma in Pregnancy and Lactation patient treatment.
Reviews
There are no reviews yet.